FDA Approves IRBESARTAN AND HYDROCHLOROTHIAZIDE — Solco Healthcare US, LLC

# FDA Approves Generic Irbesartan and Hydrochlorothiazide from Solco Healthcare Solco Healthcare US, LLC has received FDA approval for a generic formulation of irbesartan and hydrochlorothiazide, a combination antihypertensive medication, potentially expanding treatment access and creating competitive pricing pressure in the blood pressure management market. The approval of this fixed-dose combination generic is expected to increase market competition and offer cost savings for patients and payers managing hypertension.